MESO MESOBLAST LTD

Nasdaq mesoblast.com


$ 14.60 $ -0.32 (-2.14 %)    

Friday, 07-Nov-2025 15:59:43 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 14.61
$ 14.57
$ 14.00 x 3
$ 17.28 x 125
$ 14.10 - $ 14.62
$ 8.80 - $ 22.00
268,880
na
3.74B
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-sunday-mesoblast-q1-revenue-surges-to-206m-as-ryoncil-net-sales-jump-69-driven-by-wider-physician-adoption-and-reimbursement

Revenue from cell therapy products was US$20.6 million, up from US$12.9 million in the previous quarter ended June 30, 2025, an...

 mesoblast-shares-are-rising-higher-whats-behind-the-move

Mesoblast Limited (NASDAQ:MESO) shares are trading higher on Friday after the company announced that Ryoncil received a J-Code ...

 mesoblast-fy-eps-009-misses-005-estimate-sales-1720m-up-from-590m-yoy

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION